Cochrane · systematic review · CD009987

Decentralising HIV treatment in lower‐ and middle‐income countries

Kredo, T, Ford, N, Adeniyi, FB, et al. · Cochrane Database of Systematic Reviews · 2013 · Cochrane Library

HIV/AIDSAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
9
current version
GRADE rated
9
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 2 · 22.2%Low 2 · 22.2%Moderate 5 · 55.6%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Antiretroviral therapy initiated in a hospital, maintained at a health centre for HIV infected patients

Population: HIV infected patients
3 questions
OutcomeEffectEvidenceStatus / GRADE
Death or lost to care
RR 0.46 [0.29, 0.71]4 studies · 39090 participantsModerate
Downgraded: risk of bias, imprecision, inconsistency, indirectness
Lost to care
RR 0.55 [0.45, 0.69]4 studies · 39090 participantsLow
Downgraded: imprecision, inconsistency, indirectness
Death
RR 0.34 [0.13, 0.87]4 studies · 39090 participantsLow
Downgraded: risk of bias, imprecision, inconsistency, indirectness

Antiretroviral therapy started and maintained in a health centre for HIV infected patients

Population: HIV infected patients
3 questions
OutcomeEffectEvidenceStatus / GRADE
Death or lost to care
RR 0.7 [0.47, 1.02]4 studies · 56360 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency, indirectness
Lost to care
RR 0.3 [0.17, 0.54]4 studies · 56360 participantsModerate
Downgraded: risk of bias, imprecision, inconsistency, indirectness
Death
RR 1.1 [0.63, 1.92]4 studies · 55099 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency, indirectness

Decentralisation from the facility to the community for antiretroviral maintenance therapy for HIV‐infected patients on antiretroviral therapy

Population: HIV‐infected patients
3 questions
OutcomeEffectEvidenceStatus / GRADE
Death or lost to care
RR 0.95 [0.62, 1.46]2 studies · 709 participantsModerate
Downgraded: imprecision, indirectness
Lost to care
RR 0.81 [0.3, 2.21]2 studies · 709 participantsModerate
Downgraded: imprecision, indirectness
Death
RR 1.03 [0.64, 1.65]2 studies · 709 participantsModerate
Downgraded: imprecision, indirectness